NASDAQ: MBRX
Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Walter V. KlempCEO and President2024-07-02240$3.57
$856.80Sell
Walter V. KlempCEO and President2024-06-222,190$3.74
$8.19kSell
Jonathan P. FosterChief Financial Officer2024-06-221,053$3.74
$3.94kSell
Donald H. PickerChief Science Officer2024-06-22524$3.74
$1.96kSell
Walter V. KlempCEO and President2024-06-20914$3.78
$3.45kSell
Jonathan P. FosterChief Financial Officer2024-06-20636$3.78
$2.40kSell
Donald H. PickerChief Science Officer2024-06-20320$3.78
$1.21kSell
Walter V. KlempCEO and President2024-06-16406$4.14
$1.68kSell
Jonathan P. FosterChief Financial Officer2024-06-16196$4.14
$811.44Sell

1 of 1

MBRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Waldemar Priebe26.04%3,645,573$3.19MInsider
Walter V. Klemp8.09%1,132,035$990.53kInsider
Donald H. Picker4.00%560,001$490.00kInsider
Armistice Capital LLC2.27%317,586$277.89kInstitution
Lpl Financial LLC0.29%41,215$36.06kInstitution
Vanguard Group Inc0.22%30,935$27.07kInstitution
Geode Capital Management LLC0.16%22,024$19.27kInstitution
Robert E. George0.10%14,660$12.83kInsider
Blackrock Inc0.09%12,380$10.83kInstitution
Renaissance Technologies LLC0.08%11,496$10.06kInstitution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX3.32%38.32%Net Selling
SABS4.81%95.19%
CLRB11.06%8.96%Net Buying
IPA5.81%0.00%
INAB36.96%28.41%

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 3.32% institutional shareholders, 38.32% Moleculin Biotech insiders, and 58.36% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 26.04% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $3.46M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.